130 related articles for article (PubMed ID: 276382)
1. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
Miale TD; Yocum D; Yocum C
Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
[TBL] [Abstract][Full Text] [Related]
2. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
Eremeev VS; Rumyantsev AG; Akimova GV; Osipov SG; Kislyak NS; Bergolz VM
Neoplasma; 1981; 28(2):219-21. PubMed ID: 6942239
[TBL] [Abstract][Full Text] [Related]
3. Immunologic parameters of children with acute leucosis after cessation of polychemotherapy under repeated immunostimulation with intradermal B.C.G.
Blau HJ; Eggers G; Kruse H; Schulz M; Grulich M
Arch Geschwulstforsch; 1982; 52(2):123-8. PubMed ID: 6954882
[TBL] [Abstract][Full Text] [Related]
4. [Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy].
Esposito L; Benedetto N; Guerriero A
Pediatria (Napoli); 1980 Dec; 88(4):521-31. PubMed ID: 6974847
[No Abstract] [Full Text] [Related]
5. Chemoimmunotherapy of acute leukemia in children.
Bergolz VM; Kisljak NS; Eremeev VS; Rumjanzev AG; Akimova GV; Molochkina AM; Osipov SG
Neoplasma; 1978; 25(3):359-63. PubMed ID: 277786
[TBL] [Abstract][Full Text] [Related]
6. Immunological rebound following cessation of chemotherapy in 15 acute lymphoid leukemia patients in complete remission.
De Rossi G; Tribalto M; Monarca B; Bolle C; Pasqualetti D; Mandelli F
Biomedicine; 1978 Feb; 29(1):11-3. PubMed ID: 276383
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in acute leukemias. Possible applications in children.
Mahoney DH; Starling KA
Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
[TBL] [Abstract][Full Text] [Related]
8. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H
Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172
[TBL] [Abstract][Full Text] [Related]
9. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production].
Kardaszewicz E; Japa J
Acta Haematol Pol; 1975; 6(2):149-55. PubMed ID: 1057344
[TBL] [Abstract][Full Text] [Related]
10. [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study].
Ortega JJ; Javier G
Sangre (Barc); 1982; 27(3):349-57. PubMed ID: 6760428
[No Abstract] [Full Text] [Related]
11. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in previously treated acute lymphatic leukemia.
Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
[No Abstract] [Full Text] [Related]
13. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
Kaftański R
Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of the first (1962) pilot study of active immunotherapy of acute lymphoid leukaemia: a critical discussion.
Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; De Vassal F
Biomedicine; 1977 Feb; 26(1):29-35. PubMed ID: 266407
[TBL] [Abstract][Full Text] [Related]
15. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
[TBL] [Abstract][Full Text] [Related]
16. [Immunological control over the action of BCG vaccine in the chemoimmunotherapy of acute leukemia in children].
Kisliak NS; Averbakh MM; Bergolts VM; Moroz AM; Eremeev VS
Sov Med; 1978 Nov; (11):35-8. PubMed ID: 364684
[No Abstract] [Full Text] [Related]
17. The role of immunotherapy in acute myelogenous leukemia.
Foon KA; Smalley RV; Riggs CW; Gale RP
Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
[TBL] [Abstract][Full Text] [Related]
18. [Effect of immunotherapy on lymphocyte function in acute lymphatic leukemia].
Aurich G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):817-25. PubMed ID: 64422
[TBL] [Abstract][Full Text] [Related]
19. [BCG immunotherapy in children with acute lymphocytic leukemia in continuous remission after 3 years of intensive chemotherapy (protocol C-70) (author's transl)].
Ortega JJ; Javier G
Med Clin (Barc); 1982 Mar 1-15; 78(5):183-8. PubMed ID: 6952060
[No Abstract] [Full Text] [Related]
20. [Administration of BCG-CWS for the treatment of leukemia in children.--Management of acute leukemia after cessation of maintenance chemotherapy-- (author's transl)].
Ha K; Tawa A; Shu K; Ikeda T; Yabuuchi H; Nishida M
Rinsho Ketsueki; 1980 Jun; 21(6):759-67. PubMed ID: 6936563
[No Abstract] [Full Text] [Related]
[Next] [New Search]
